Ventricular Assist Devices (VAD) Global Market - Forecast to 2023
The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The ventricular assist devices (VAD) are used to treat end stage heart failure. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body.
Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR).
This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report.
The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
The Ventricular assist devicesis expected to grow at a strong CAGR during 2016 to 2023. Increasing incidences of cardiovascular diseases due to change in lifestyle, shortage of donor heart, Rise in the number of heart failure, shortage of donor heart, increasing ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the ventricular assist devices global market. Many entry level barriers, stringent regulations, high cost of the device, adverse events due to VAD implant and lack of skilled and trained professionals are some of the factors hampering the growth of Ventricular assist devices market.
The ventricular assist devices global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR).
This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report.
The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
The Ventricular assist devicesis expected to grow at a strong CAGR during 2016 to 2023. Increasing incidences of cardiovascular diseases due to change in lifestyle, shortage of donor heart, Rise in the number of heart failure, shortage of donor heart, increasing ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the ventricular assist devices global market. Many entry level barriers, stringent regulations, high cost of the device, adverse events due to VAD implant and lack of skilled and trained professionals are some of the factors hampering the growth of Ventricular assist devices market.
The ventricular assist devices global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Others
- Europe
- Germany
- France
- U.K.
- Others
- Asia-Pacific
- Japan
- China
- India
- Others
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase incidence of heart failure
3.3.1.2 Shortage of heart donors
3.3.1.3 Technological advancements in VAD
3.3.1.4 Rising geriatric population
3.3.1.5 Vast pipeline products
3.3.1.6 Expansion of LVAD centres in emerging countries
3.3.1.7 New product launches
3.3.1.8 Increase in funding for LVAD research
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Adverse events and complication with the implantations of VAD
3.3.2.2 Cost of the devices
3.3.2.3 Stringent regulatory guidelines
3.3.2.4 Lack of skilled and trained professionals
3.3.2.5 Availability of alternative products
3.3.2.6 Reimbursement issues in emerging countries
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 JAPAN
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.5.1.1 Ventricular assist device reimbursement
3.5.1.2 VAD physician reimbursement
3.6 CLINICL TRIAL DATA
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 WIRELESS HEART PUMP
3.8.3 MINIATURIZATION OF IMPLANTABLE VENTRICULAR ASSIST DEVICES
3.8.4 VAD APPLICATION
3.8.5 SUPPORTING TOOLS FOR LVAD IMPLANTATION
3.8.6 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 COMPETITIVE RIVALRY
3.10 SUPPLY CHAIN ANALYSIS
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.12 VENTRICULAR ASSIST DEVICES NUMBER OF UNITS BY REGION
3.12.1 EXTRACORPOREAL VENTRICULAR ASSIST DEVICES
3.12.2 INTRACORPOREAL VENTRICULAR ASSIST DEVICES
3.12.3 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
3.13 COMPARISON OF VENTRICULAR ASSIST DEVICES
4 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 LEFT VENTRICULAR ASSIST DEVICES (LVAD)
4.3 RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
4.4 BI-VENTRICULAR ASSIST DEVICES (BIVAD)
5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE
5.1 INTRODUCTION
5.2 EXTRACORPOREAL VAD
5.3 INTRACORPOREAL VAD
5.4 PERCUTANEOUS VAD
6 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE
6.1 INTRODUCTION
6.2 PULSATILE FLOW PUMP
6.3 CONTINUOUS FLOW PUMP
6.3.1 CENTRIFUGAL FLOW PUMP
6.3.2 AXIAL FLOW PUMP
7 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE
7.1 INTRODUCTION
7.2 PEDIATRIC VAD
7.3 ADULT VAD
8 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BRIDGE TO TRANSPLANT (BTT)
8.3 BRIDGE TO DESTINATION THERAPY (BTD)
8.4 BRIDGE TO RECOVERY (BTR)
9 REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 OTHERS
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 OTHERS
9.4 APAC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 OTHERS
9.5 ROW
9.5.1 BRAZIL
9.5.2 REST OF LATIN AMERICA
9.5.3 MIDDLE EAST AND OTHERS
10 COMPANY DEVELOPMENTS
10.1 INTRODUCTION
10.2 APPROVALS
10.3 ACQUISITIONS
10.4 PARTNERSHIPS
10.5 OTHER DEVELOPMENTS
11 MAJOR COMPANIES
11.1 ABBOTT LABORATORIES
11.1.1 OVERVIEW
11.1.2 FINANCIALS
11.1.3 PRODUCT PORTFOLIO
11.1.4 KEY DEVELOPMENTS
11.1.5 BUSINESS STRATEGY
11.1.6 SWOT ANALYSIS
11.2 ABIOMED, INC.
11.2.1 OVERVIEW
11.2.2 FINANCIALS
11.2.3 PRODUCT PORTFOLIO
11.2.4 KEY DEVELOPMENTS
11.2.5 BUSINESS STRATEGY
11.2.6 SWOT ANALYSIS
11.3 BERLIN HEART GMBH
11.3.1 OVERVIEW
11.3.2 FINANCIALS
11.3.3 PRODUCT PORTFOLIO
11.3.4 KEY DEVELOPMENTS
11.3.5 BUSINESS STRATEGY
11.3.6 SWOT ANALYSIS
11.4 EVAHEART, INC.
11.4.1 OVERVIEW
11.4.2 FINANCIALS
11.4.3 PRODUCT PORTFOLIO
11.4.4 KEY DEVELOPMENTS
11.4.5 BUSINESS STRATEGY
11.4.6 SWOT ANALYSIS
11.5 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
11.5.1 OVERVIEW
11.5.2 FINANCIALS
11.5.3 PRODUCT PORTFOLIO
11.5.4 KEY DEVELOPMNTS
11.5.5 BUSINESS STRATEGY
11.5.6 SWOT ANALYSIS
11.6 JARVIK HEART INC.
11.6.1 OVERVIEW
11.6.2 FINANCIALS
11.6.3 PRODUCT PORTFOLIO
11.6.4 KEY DEVELOPMNTS
11.6.5 BUSINESS STRATEGY
11.6.6 SWOT ANALYSIS
11.7 MEDTRONIC PLC
11.7.1 OVERVIEW
11.7.2 FINANCIALS
11.7.3 PRODUCT PORTFOLIO
11.7.4 KEY DEVELOPMENTS
11.7.5 BUSINESS STRATEGY
11.7.6 SWOT ANALYSIS
11.8 RELIANTHEART INC.
11.8.1 OVERVIEW
11.8.2 FINANCIALS
11.8.3 PRODUCT PORTFOLIO
11.8.4 KEY DEVELOPMNTS
11.8.5 BUSINESS STRATEGY
11.8.6 SWOT ANALYSIS
11.9 TANDEMLIFE
11.9.1 OVERVIEW
11.9.2 FINANCIALS
11.9.3 PRODUCT PORTFOLIO
11.9.4 KEY DEVELOPMNTS
11.9.5 BUSINESS STRATEGY
11.9.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase incidence of heart failure
3.3.1.2 Shortage of heart donors
3.3.1.3 Technological advancements in VAD
3.3.1.4 Rising geriatric population
3.3.1.5 Vast pipeline products
3.3.1.6 Expansion of LVAD centres in emerging countries
3.3.1.7 New product launches
3.3.1.8 Increase in funding for LVAD research
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Adverse events and complication with the implantations of VAD
3.3.2.2 Cost of the devices
3.3.2.3 Stringent regulatory guidelines
3.3.2.4 Lack of skilled and trained professionals
3.3.2.5 Availability of alternative products
3.3.2.6 Reimbursement issues in emerging countries
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 JAPAN
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.5.1.1 Ventricular assist device reimbursement
3.5.1.2 VAD physician reimbursement
3.6 CLINICL TRIAL DATA
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 WIRELESS HEART PUMP
3.8.3 MINIATURIZATION OF IMPLANTABLE VENTRICULAR ASSIST DEVICES
3.8.4 VAD APPLICATION
3.8.5 SUPPORTING TOOLS FOR LVAD IMPLANTATION
3.8.6 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 COMPETITIVE RIVALRY
3.10 SUPPLY CHAIN ANALYSIS
3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.12 VENTRICULAR ASSIST DEVICES NUMBER OF UNITS BY REGION
3.12.1 EXTRACORPOREAL VENTRICULAR ASSIST DEVICES
3.12.2 INTRACORPOREAL VENTRICULAR ASSIST DEVICES
3.12.3 PERCUTANEOUS VENTRICULAR ASSIST DEVICES
3.13 COMPARISON OF VENTRICULAR ASSIST DEVICES
4 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 LEFT VENTRICULAR ASSIST DEVICES (LVAD)
4.3 RIGHT VENTRICULAR ASSIST DEVICES (RVAD)
4.4 BI-VENTRICULAR ASSIST DEVICES (BIVAD)
5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE
5.1 INTRODUCTION
5.2 EXTRACORPOREAL VAD
5.3 INTRACORPOREAL VAD
5.4 PERCUTANEOUS VAD
6 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE
6.1 INTRODUCTION
6.2 PULSATILE FLOW PUMP
6.3 CONTINUOUS FLOW PUMP
6.3.1 CENTRIFUGAL FLOW PUMP
6.3.2 AXIAL FLOW PUMP
7 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE
7.1 INTRODUCTION
7.2 PEDIATRIC VAD
7.3 ADULT VAD
8 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BRIDGE TO TRANSPLANT (BTT)
8.3 BRIDGE TO DESTINATION THERAPY (BTD)
8.4 BRIDGE TO RECOVERY (BTR)
9 REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 OTHERS
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 OTHERS
9.4 APAC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 OTHERS
9.5 ROW
9.5.1 BRAZIL
9.5.2 REST OF LATIN AMERICA
9.5.3 MIDDLE EAST AND OTHERS
10 COMPANY DEVELOPMENTS
10.1 INTRODUCTION
10.2 APPROVALS
10.3 ACQUISITIONS
10.4 PARTNERSHIPS
10.5 OTHER DEVELOPMENTS
11 MAJOR COMPANIES
11.1 ABBOTT LABORATORIES
11.1.1 OVERVIEW
11.1.2 FINANCIALS
11.1.3 PRODUCT PORTFOLIO
11.1.4 KEY DEVELOPMENTS
11.1.5 BUSINESS STRATEGY
11.1.6 SWOT ANALYSIS
11.2 ABIOMED, INC.
11.2.1 OVERVIEW
11.2.2 FINANCIALS
11.2.3 PRODUCT PORTFOLIO
11.2.4 KEY DEVELOPMENTS
11.2.5 BUSINESS STRATEGY
11.2.6 SWOT ANALYSIS
11.3 BERLIN HEART GMBH
11.3.1 OVERVIEW
11.3.2 FINANCIALS
11.3.3 PRODUCT PORTFOLIO
11.3.4 KEY DEVELOPMENTS
11.3.5 BUSINESS STRATEGY
11.3.6 SWOT ANALYSIS
11.4 EVAHEART, INC.
11.4.1 OVERVIEW
11.4.2 FINANCIALS
11.4.3 PRODUCT PORTFOLIO
11.4.4 KEY DEVELOPMENTS
11.4.5 BUSINESS STRATEGY
11.4.6 SWOT ANALYSIS
11.5 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG)
11.5.1 OVERVIEW
11.5.2 FINANCIALS
11.5.3 PRODUCT PORTFOLIO
11.5.4 KEY DEVELOPMNTS
11.5.5 BUSINESS STRATEGY
11.5.6 SWOT ANALYSIS
11.6 JARVIK HEART INC.
11.6.1 OVERVIEW
11.6.2 FINANCIALS
11.6.3 PRODUCT PORTFOLIO
11.6.4 KEY DEVELOPMNTS
11.6.5 BUSINESS STRATEGY
11.6.6 SWOT ANALYSIS
11.7 MEDTRONIC PLC
11.7.1 OVERVIEW
11.7.2 FINANCIALS
11.7.3 PRODUCT PORTFOLIO
11.7.4 KEY DEVELOPMENTS
11.7.5 BUSINESS STRATEGY
11.7.6 SWOT ANALYSIS
11.8 RELIANTHEART INC.
11.8.1 OVERVIEW
11.8.2 FINANCIALS
11.8.3 PRODUCT PORTFOLIO
11.8.4 KEY DEVELOPMNTS
11.8.5 BUSINESS STRATEGY
11.8.6 SWOT ANALYSIS
11.9 TANDEMLIFE
11.9.1 OVERVIEW
11.9.2 FINANCIALS
11.9.3 PRODUCT PORTFOLIO
11.9.4 KEY DEVELOPMNTS
11.9.5 BUSINESS STRATEGY
11.9.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
TABLE 2 EXTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 3 INTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 4 PERCUTANEOUS VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 6 LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 7 RIGHT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 8 BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 9 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 10 EXTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 11 INTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 12 PERCUTANEOUS VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 13 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 14 PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 15 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 16 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 17 CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 18 AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 19 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 20 PEDIATRIC VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 21 ADULT VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 22 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 23 BRIDGE TO TRANSPLANT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 24 BRIDGE TO DESTINATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 25 BRIDGE TO RECOVERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 26 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
TABLE 27 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 28 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 29 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 30 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 31 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 32 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 33 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 34 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 35 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 36 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 37 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 38 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 39 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 40 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 41 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 42 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 43 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 44 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 45 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 46 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 47 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 48 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 49 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 50 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 51 APPROVALS, (2015-2017)
TABLE 52 ACQUISITIONS (2015-2017)
TABLE 53 PARTNERSHIPS (2015-2017)
TABLE 54 OTHER DEVELOPMENTS (2015-2017)
TABLE 55 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 56 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
TABLE 57 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 58 ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 59 ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 60 FRESENIUS MEDICAL CARE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 61 FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 62 FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 63 MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 64 MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 65 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 66 MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 1 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
TABLE 2 EXTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 3 INTRACORPOREAL VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 4 PERCUTANEOUS VAD NUMBER OF UNITS, BY REGION, (2015-2023) (NO’S)
TABLE 5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
TABLE 6 LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 7 RIGHT VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 8 BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 9 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 10 EXTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 11 INTRACORPOREAL VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 12 PERCUTANEOUS VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 13 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 14 PULSATILE FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 15 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 16 CONTINUOUS FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 17 CENTRIFUGAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 18 AXIAL FLOW PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 19 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 20 PEDIATRIC VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 21 ADULT VAD GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 22 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 23 BRIDGE TO TRANSPLANT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 24 BRIDGE TO DESTINATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 25 BRIDGE TO RECOVERY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
TABLE 26 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
TABLE 27 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 28 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 29 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 30 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 31 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 32 NORTH AMERICAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 33 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 34 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 35 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 36 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 37 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 38 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 39 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 40 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 41 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 42 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 43 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 44 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 45 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
TABLE 46 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE, (2015-2023) ($MN)
TABLE 47 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PUMP TYPE, (2015-2023) ($MN)
TABLE 48 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PATIENT TYPE, (2015-2023) ($MN)
TABLE 49 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
TABLE 50 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
TABLE 51 APPROVALS, (2015-2017)
TABLE 52 ACQUISITIONS (2015-2017)
TABLE 53 PARTNERSHIPS (2015-2017)
TABLE 54 OTHER DEVELOPMENTS (2015-2017)
TABLE 55 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 56 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
TABLE 57 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
TABLE 58 ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 59 ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 60 FRESENIUS MEDICAL CARE: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 61 FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 62 FRESENIUS MEDICAL CARE: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
TABLE 63 MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
TABLE 64 MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 65 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
TABLE 66 MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
FIGURE 1 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: VENTRICULAR ASSIST DEVICES GLOBAL MARKET
FIGURE 3 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 VENTRICULAR ASSIST DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 VENTRICULAR ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
FIGURE 9 VENTRICULAR ASSIST DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 VENTRICULAR ASSIST DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 VENTRICULAR ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
FIGURE 12 EXTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
FIGURE 13 INTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
FIGURE 14 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 15 LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 16 RIGHT VENTRICUALR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION (2016 V/S 2023) (%)
FIGURE 17 BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 18 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE (2016 V/S 2023) ($MN)
FIGURE 19 EXTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 20 INTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 21 PERCUTANEOUS VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 22 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE (2016 V/S 2023) ($MN)
FIGURE 23 PULSATILE FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 24 CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 25 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 26 PEDIATRIC VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 27 ADULT VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 28 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
FIGURE 29 BRIDGE TO TRANSPLANT GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 30 BRIDGE TO DESTINATION THERAPY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 31 BRIDGE TO RECOVERY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 32 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
FIGURE 33 NORTH AMERICA VENTRICULAR ASSIST DEVICESREVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 34 NORTH AMERICA VENTRICULAR ASSIST DEVICESREVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 35 U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 36 U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 37 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 38 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 39 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 40 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 41 GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 42 GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 43 FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 44 FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 45 U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 46 U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 47 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 48 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 49 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 50 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 51 JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 52 JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 53 CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 54 CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 55 INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 56 INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 57 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 58 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 59 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 60 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 61 BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 62 BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 63 REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 64 REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 65 MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 66 MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 67 KEY GROWTH STRATEGIES, (2015-2017)
FIGURE 68 SWOT: ABBOTT LABORATORIES
FIGURE 69 SWOT: ABIOMED
FIGURE 70 SWOT: BERLIN HEART GMBH
FIGURE 71 SWOT: EVAHEART INC.
FIGURE 72 SWOT: FRESENIUS MEDICAL CARE (XENIOS AG)
FIGURE 73 SWOT: JARVIK HEART, INC.
FIGURE 74 SWOT: MEDTRONIC
FIGURE 75 SWOT: RELIANTHEART, INC.
FIGURE 76 SWOT: TANDEMLIFE
FIGURE 1 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: VENTRICULAR ASSIST DEVICES GLOBAL MARKET
FIGURE 3 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 VENTRICULAR ASSIST DEVICES GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 VENTRICULAR ASSIST DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
FIGURE 9 VENTRICULAR ASSIST DEVICE GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 VENTRICULAR ASSIST DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 VENTRICULAR ASSIST DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
FIGURE 12 EXTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
FIGURE 13 INTRACORPOREAL VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2016 V/S 2023) (NO’S)
FIGURE 14 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
FIGURE 15 LEFT VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 16 RIGHT VENTRICUALR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION (2016 V/S 2023) (%)
FIGURE 17 BI-VENTRICULAR ASSIST DEVICES GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 18 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY IMPLANT TYPE (2016 V/S 2023) ($MN)
FIGURE 19 EXTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 20 INTRACORPOREAL VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 21 PERCUTANEOUS VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 22 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PUMP TYPE (2016 V/S 2023) ($MN)
FIGURE 23 PULSATILE FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 24 CONTINUOUS FLOW PUMP GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 25 VENTRICULAR ASSIST DEVICES GLOBAL MARKET REVENUE, BY PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 26 PEDIATRIC VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 27 ADULT VAD GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 28 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
FIGURE 29 BRIDGE TO TRANSPLANT GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 30 BRIDGE TO DESTINATION THERAPY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 31 BRIDGE TO RECOVERY GLOBAL MARKET SHARE, BY REGION, (2016 V/S 2023) (%)
FIGURE 32 VENTRICULAR ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN), CAGR (%)
FIGURE 33 NORTH AMERICA VENTRICULAR ASSIST DEVICESREVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 34 NORTH AMERICA VENTRICULAR ASSIST DEVICESREVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 35 U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCTS/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 36 U.S. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 37 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 38 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 39 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 40 EUROPE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 41 GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 42 GERMANY VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 43 FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 44 FRANCE VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 45 U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 46 U.K. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 47 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 48 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 49 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 50 APAC VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 51 JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 52 JAPAN VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 53 CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 54 CHINA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 55 INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 56 INDIA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 57 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 58 OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 59 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 60 ROW VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 61 BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 62 BRAZIL VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 63 REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 64 REST OF LATIN AMERICA VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 65 MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY PRODUCT/APPLICATION (2016 V/S 2023) ($MN)
FIGURE 66 MIDDLE EAST AND OTHERS VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY IMPLANT TYPE/PUMP TYPE/PATIENT TYPE (2016 V/S 2023) ($MN)
FIGURE 67 KEY GROWTH STRATEGIES, (2015-2017)
FIGURE 68 SWOT: ABBOTT LABORATORIES
FIGURE 69 SWOT: ABIOMED
FIGURE 70 SWOT: BERLIN HEART GMBH
FIGURE 71 SWOT: EVAHEART INC.
FIGURE 72 SWOT: FRESENIUS MEDICAL CARE (XENIOS AG)
FIGURE 73 SWOT: JARVIK HEART, INC.
FIGURE 74 SWOT: MEDTRONIC
FIGURE 75 SWOT: RELIANTHEART, INC.
FIGURE 76 SWOT: TANDEMLIFE
